346 related articles for article (PubMed ID: 27535130)
1. The prognostic potential of alternative transcript isoforms across human tumors.
Trincado JL; Sebestyén E; Pagés A; Eyras E
Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous Melanoma.
Dunkel Y; Reid AL; Ear J; Aznar N; Millward M; Gray E; Pearce R; Ziman M; Ghosh P
Sci Rep; 2018 Dec; 8(1):18036. PubMed ID: 30575751
[TBL] [Abstract][Full Text] [Related]
4. Review and cross-validation of gene expression signatures and melanoma prognosis.
Schramm SJ; Campain AE; Scolyer RA; Yang YH; Mann GJ
J Invest Dermatol; 2012 Feb; 132(2):274-83. PubMed ID: 21956122
[TBL] [Abstract][Full Text] [Related]
5. Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.
Lanigan F; Brien GL; Fan Y; Madden SF; Jerman E; Maratha A; Aloraifi F; Hokamp K; Dunne EJ; Lohan AJ; Flanagan L; Garbe JC; Stampfer MR; Fridberg M; Jirstrom K; Quinn CM; Loftus B; Gallagher WM; Geraghty J; Bracken AP
FEBS J; 2015 Sep; 282(18):3455-73. PubMed ID: 26094870
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.
Figueroa JD; Yang H; Garcia-Closas M; Davis S; Meltzer P; Lissowska J; Horne HN; Sherman ME; Lee M
Breast Cancer Res Treat; 2015 Apr; 150(2):457-466. PubMed ID: 25773928
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
[TBL] [Abstract][Full Text] [Related]
8. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
[TBL] [Abstract][Full Text] [Related]
9. Detection of gene expression in sentinel lymph node of primary breast cancer patients.
Soleimani S; Alizadeh Shargh S; Keramatinia A; Mehrvar N; Mansouri N; Doosti A; Mortazavi-Tabatabaei SA; Hashemi M; Movafagh A
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):118-121. PubMed ID: 29729704
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers.
Gökmen-Polar Y; Vladislav IT; Neelamraju Y; Janga SC; Badve S
Sci Rep; 2015 Mar; 5():8765. PubMed ID: 25739705
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.
Thakur R; Laye JP; Lauss M; Diaz JMS; O'Shea SJ; Poźniak J; Filia A; Harland M; Gascoyne J; Randerson-Moor JA; Chan M; Mell T; Jönsson G; Bishop DT; Newton-Bishop J; Barrett JH; Nsengimana J
Clin Cancer Res; 2019 Dec; 25(24):7424-7435. PubMed ID: 31515461
[TBL] [Abstract][Full Text] [Related]
12. Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.
Jayawardana K; Schramm SJ; Tembe V; Mueller S; Thompson JF; Scolyer RA; Mann GJ; Yang J
J Invest Dermatol; 2016 Jan; 136(1):245-254. PubMed ID: 26763444
[TBL] [Abstract][Full Text] [Related]
13. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.
Murphy LC; Hilsenbeck SG; Dotzlaw H; Fuqua SA
Clin Cancer Res; 1995 Feb; 1(2):155-9. PubMed ID: 9815968
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node biopsy for melanoma: an update after two decades of experience.
Ross MI
Semin Cutan Med Surg; 2010 Dec; 29(4):238-48. PubMed ID: 21277537
[TBL] [Abstract][Full Text] [Related]
15. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.
Bemmo A; Dias C; Rose AA; Russo C; Siegel P; Majewski J
PLoS One; 2010 Aug; 5(8):e11981. PubMed ID: 20700505
[TBL] [Abstract][Full Text] [Related]
16. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
[TBL] [Abstract][Full Text] [Related]
17. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
18. Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
Staaf J; Ringnér M; Vallon-Christersson J; Jönsson G; Bendahl PO; Holm K; Arason A; Gunnarsson H; Hegardt C; Agnarsson BA; Luts L; Grabau D; Fernö M; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
J Clin Oncol; 2010 Apr; 28(11):1813-20. PubMed ID: 20231686
[TBL] [Abstract][Full Text] [Related]
19. Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2014; 22(2):142-5. PubMed ID: 23958542
[TBL] [Abstract][Full Text] [Related]
20. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
